Isshiki T, Pegram B L, Frohlich E D
Division of Research, Alton Ochsner Medical Foundation, New Orleans, Louisiana 70121.
Am J Cardiol. 1988 Oct 5;62(11):79G-84G. doi: 10.1016/0002-9149(88)90037-9.
Systemic and regional hemodynamic effects of 2 benzothiazepine derivatives, diltiazem and its congener TA-3090, were studied both acutely and chronically in spontaneously hypertensive (SHR) and normotensive Wistar-Kyoto (WKY) rats. All hemodynamic data were obtained in the conscious state using the reference sample radiomicrosphere method. Mean arterial pressure was reduced significantly with both immediate and more long-term treatment with both drugs in the SHR. The hypotensive action of TA-3090 was about 3 times as potent as diltiazem. The pressure reduction with both drugs was associated with a decrease in total peripheral resistance. TA-3090 seemed to have lesser effect on heart rate than diltiazem, although its net effect on cardiac output was similar, remaining unchanged in each study group. After intravenous injection, both diltiazem and TA-3090 significantly reduced vascular resistances of the major target organs of hypertension: heart, brain and kidneys in SHR. However, with prolonged treatment, organ vascular resistances seemed to be nonuniformly distributed. Intrarenal hemodynamics revealed significant differences between SHR and WKY rats after intravenous diltiazem and prolonged treatment with TA-3090. Thus, efferent as well as afferent arteriolar resistance decreased and therefore calculated glomerular capillary hydrostatic pressure decreased in SHR; however, efferent resistance and glomerular pressure remained unchanged in WKY rats. In contrast, intravenous TA-3090 evoked no such differences. Thus, diltiazem as well as TA-3090 dilated efferent as well as afferent arterioles in the SHR but not in the WKY rats. This effect was associated with a reduction in glomerular capillary pressure, preventing glomerular hyperfiltration through efferent arteriolar dilation.(ABSTRACT TRUNCATED AT 250 WORDS)
在自发性高血压(SHR)大鼠和正常血压的Wistar-Kyoto(WKY)大鼠中,对两种苯并噻氮䓬衍生物地尔硫䓬及其同类物TA-3090的全身和局部血流动力学效应进行了急性和慢性研究。所有血流动力学数据均在清醒状态下使用参考样本放射性微球法获得。在SHR大鼠中,两种药物的即刻和长期治疗均显著降低了平均动脉压。TA-3090的降压作用约为地尔硫䓬的3倍。两种药物降压均伴有总外周阻力降低。TA-3090对心率的影响似乎比地尔硫䓬小,尽管其对心输出量的净效应相似,各研究组均保持不变。静脉注射后,地尔硫䓬和TA-3090均显著降低了SHR大鼠高血压主要靶器官(心脏、脑和肾脏)的血管阻力。然而,长期治疗后,器官血管阻力似乎分布不均。静脉注射地尔硫䓬和TA-3090长期治疗后,SHR大鼠和WKY大鼠的肾内血流动力学显示出显著差异。因此,SHR大鼠的出球小动脉和入球小动脉阻力均降低,计算得出的肾小球毛细血管静水压降低;然而,WKY大鼠的出球小动脉阻力和肾小球压力保持不变。相比之下,静脉注射TA-3090未引起此类差异。因此,地尔硫䓬和TA-3090均可使SHR大鼠的出球小动脉和入球小动脉扩张,但对WKY大鼠无效。这种效应与肾小球毛细血管压力降低有关,通过出球小动脉扩张防止肾小球超滤过。(摘要截短至250字)